FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3011678751> ?p ?o ?g. }

• W3011678751 endingPage "209" @default.
• W3011678751 startingPage "194" @default.
• W3011678751 abstract "Cardiac allograft vasculopathy (CAV)—mediated by a heterogeneous myriad of immune and non-immune factors, which contribute to the progressive and diffuse thickening of the arterial allograft's tunica intima in one distinct form of CAV, and the build-up of plaque in another—is a major limiting factor of long-term survival post heart transplantation. Information on the optimal pharmacotherapeutic approaches for the prevention and management of CAV is conflicting, scattered, and inconsistent, with numerous recent studies adding to the literature. In this paper, we present a go-to clinical resource with the most updated and comprehensive information on the topic. Immunosuppressant therapy remains a staple, with mTOR inhibitors and mycophenolate mofetil (MMF) showing direct correlation with CAV prevention. More data is now available with calcineurin inhibitor (CNI) minimizing or sparing regimens. More novel approaches are being investigated for the roles of monoclonal antibodies, anti-thymocyte globulin, and bortezomib in preventing or delaying CAV. On the other hand, statins' established efficacy is attributed to lipid-lowering and lipid-independent immunomodulatory effects, with early initiation associated with improved outcomes. The choice of statin is dependent on drug-drug interactions. Other aiding approaches for the prevention of CAV include antioxidant vitamins, aspirin, vasodilators, folate therapy, and, most pertinently, cytomegalovirus prophylaxis. Larger clinical trials are needed before these options are institutionalised. For management of established CAV, early initiation of augmented immunosuppressive therapies may be effective, as well as CNI conversion to mTOR inhibitors with or without standard MMF and azathioprine therapy. Risk of acute rejection needs to be monitored during conversion. Finally, preclinical investigations highlight novel potential therapies for CAV prevention and attenuation, however robust clinical trials are needed to test their efficacy and safety." @default.
• W3011678751 created "2020-03-23" @default.
• W3011678751 creator A5015471306 @default.
• W3011678751 creator A5029540739 @default.
• W3011678751 creator A5051519703 @default.
• W3011678751 creator A5056960938 @default.
• W3011678751 creator A5065748983 @default.
• W3011678751 creator A5075270916 @default.
• W3011678751 creator A5090537128 @default.
• W3011678751 date "2020-05-01" @default.
• W3011678751 modified "2023-10-18" @default.
• W3011678751 title "Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy" @default.
• W3011678751 cites W1777221585 @default.
• W3011678751 cites W1798795371 @default.
• W3011678751 cites W1963704561 @default.
• W3011678751 cites W1964299433 @default.
• W3011678751 cites W1970601178 @default.
• W3011678751 cites W1973776052 @default.
• W3011678751 cites W1977137895 @default.
• W3011678751 cites W1979341854 @default.
• W3011678751 cites W1980474822 @default.
• W3011678751 cites W1986382812 @default.
• W3011678751 cites W1991529818 @default.
• W3011678751 cites W1992704984 @default.
• W3011678751 cites W1996441685 @default.
• W3011678751 cites W1997597009 @default.
• W3011678751 cites W2000718582 @default.
• W3011678751 cites W2013530401 @default.
• W3011678751 cites W2015638436 @default.
• W3011678751 cites W2022981957 @default.
• W3011678751 cites W2027447956 @default.
• W3011678751 cites W2030146228 @default.
• W3011678751 cites W2035881418 @default.
• W3011678751 cites W2040605215 @default.
• W3011678751 cites W2042107653 @default.
• W3011678751 cites W2054627746 @default.
• W3011678751 cites W2058888204 @default.
• W3011678751 cites W2062643000 @default.
• W3011678751 cites W2067329441 @default.
• W3011678751 cites W2070128988 @default.
• W3011678751 cites W2081613905 @default.
• W3011678751 cites W2093182570 @default.
• W3011678751 cites W2117628687 @default.
• W3011678751 cites W2122783053 @default.
• W3011678751 cites W2127139374 @default.
• W3011678751 cites W2127831802 @default.
• W3011678751 cites W2148124392 @default.
• W3011678751 cites W2150067525 @default.
• W3011678751 cites W2151405819 @default.
• W3011678751 cites W2155178079 @default.
• W3011678751 cites W2169093103 @default.
• W3011678751 cites W2171906067 @default.
• W3011678751 cites W2172064850 @default.
• W3011678751 cites W2225927169 @default.
• W3011678751 cites W2272121251 @default.
• W3011678751 cites W2296410414 @default.
• W3011678751 cites W2299639185 @default.
• W3011678751 cites W2320819238 @default.
• W3011678751 cites W2324005683 @default.
• W3011678751 cites W2331495719 @default.
• W3011678751 cites W2334425173 @default.
• W3011678751 cites W2336501769 @default.
• W3011678751 cites W2338977280 @default.
• W3011678751 cites W2471777514 @default.
• W3011678751 cites W2535158955 @default.
• W3011678751 cites W2550232018 @default.
• W3011678751 cites W2616230897 @default.
• W3011678751 cites W2621493963 @default.
• W3011678751 cites W2729531794 @default.
• W3011678751 cites W2748242937 @default.
• W3011678751 cites W2764038337 @default.
• W3011678751 cites W2767070206 @default.
• W3011678751 cites W2790607178 @default.
• W3011678751 cites W2791672301 @default.
• W3011678751 cites W2794690165 @default.
• W3011678751 cites W2795135234 @default.
• W3011678751 cites W2797853852 @default.
• W3011678751 cites W2809604869 @default.
• W3011678751 cites W2884740736 @default.
• W3011678751 cites W2889866508 @default.
• W3011678751 cites W2893703990 @default.
• W3011678751 cites W2910060757 @default.
• W3011678751 cites W2910812364 @default.
• W3011678751 cites W2913854502 @default.
• W3011678751 cites W2921359912 @default.
• W3011678751 cites W2922435619 @default.
• W3011678751 cites W2925274503 @default.
• W3011678751 cites W2947374716 @default.
• W3011678751 cites W2955740907 @default.
• W3011678751 cites W2967684659 @default.
• W3011678751 cites W2969879461 @default.
• W3011678751 cites W2970160543 @default.
• W3011678751 cites W2971361433 @default.
• W3011678751 cites W2972587564 @default.
• W3011678751 cites W2974145770 @default.
• W3011678751 cites W2996448489 @default.
• W3011678751 cites W3009963840 @default.
• W3011678751 cites W4211207317 @default.

• next